H. Res. 942 is a nonbinding House resolution that expresses support for recognizing September 2025 as "National Childhood Cancer Awareness Month." The text frames the designation with basic findings about incidence, mortality, improving survival rates, and the long-term health burdens survivors face.
The resolution is purely symbolic: it asks federal, state, and local governments and nonprofit organizations to observe the month and encourages lifelong medical monitoring for survivors. Its significance lies in the potential to focus public attention and policy discussion on survivorship care and pediatric cancer outcomes without creating new statutory authorities or funding streams.
At a Glance
What It Does
H. Res. 942 formally expresses support for designating September 2025 as a month of national awareness; it contains recommendations (not mandates) that government bodies and nonprofits observe the month and that survivors receive ongoing monitoring. The resolution contains no appropriation, regulatory changes, or enforcement mechanisms.
Who It Affects
The resolution primarily speaks to federal agencies, state and local public-health entities, nonprofit advocacy groups, pediatric oncology providers, survivors and their families. Because it is nonbinding, private-sector obligations do not change, but advocacy and public-health actors are the intended audience for observance activities.
Why It Matters
Symbolic congressional recognition can amplify fundraising, awareness campaigns, and calls for improved survivorship care. For professionals, the resolution signals congressional attention to pediatric oncology outcomes and may increase pressure for legislative or administrative follow-up on gaps in long-term care and research funding.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
H. Res. 942 is a short, single-subject House resolution that sets out several factual findings about childhood cancer—annual diagnoses and deaths, progress in five-year survival, and the high incidence of late effects among survivors—and then lists six formal clauses asking for national recognition, observance, survivor monitoring, a public-health priority posture, and commendation of affected children.
Because the instrument is a House resolution, it does not change law, allocate money, or create new federal programs; it operates as a formal expression of the Houses sentiment.
Practically, the resolution asks the Federal Government, States, localities, and nonprofit organizations to observe September 2025 through programs and activities aimed at increasing public knowledge of childhood cancer risks. That request is directed at bodies that already run awareness campaigns, so the immediate operational impact is limited to coordination, messaging, and event planning unless followed by future legislation or appropriations.On clinical and policy fronts, the resolution explicitly encourages survivors to pursue ongoing monitoring throughout adulthood and frames prevention and cure as public-health priorities.
It does not define standards for monitoring, assign responsibility for coverage, or require specific research investments—so the clinical recommendation is aspirational rather than prescriptive.Because the resolution includes specific statistics (for example, the bill cites about 14,500 diagnoses and roughly 1,600 deaths annually and notes an improvement in five-year survival to 85 percent by 2025), it provides a data-based rationale for awareness activities. Those statistics can be used by advocacy groups and public-health officials when designing outreach, but the resolution leaves follow-on policy choices—funding, service design, and monitoring pathways—to others.
The Five Things You Need to Know
H. Res. 942 is a nonbinding House resolution that expresses support for recognizing September 2025 as National Childhood Cancer Awareness Month.
The resolution requests that the Federal Government, States, localities, and nonprofit organizations observe the month with programs and activities intended to increase public knowledge of childhood cancer risks.
It encourages survivors of childhood cancer to receive ongoing monitoring and care throughout their adult lives, but it does not define monitoring standards or funding sources.
The text cites key findings: roughly 14,500 annual diagnoses among children under 19, about 1,600 annual deaths, a stated five-year survival increase to 85 percent by 2025, and a high rate (60–90% range cited) of chronic conditions among survivors.
H. Res. 942 makes a public-health pledge—calling prevention and cure for childhood cancer a public-health priority—and offers formal recognition and commendation of affected children rather than creating legal obligations or appropriations.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Findings on incidence, mortality, survival, and survivorship issues
The preamble compiles the bill's factual statements: annual diagnosis and death counts, childhood cancer's position among leading causes of death in children, the reported rise in five-year survival to 85 percent by 2025, and the prevalence of late effects and chronic conditions among survivors. These findings serve only as the resolution's rationale; they do not trigger programmatic obligations but provide talking points for advocacy and public-health messaging.
Formal expression of support for the designation
Clause (1) states the House's support for designating September 2025 as "National Childhood Cancer Awareness Month." This is a symbolic congressional endorsement—important for signaling priorities but lacking legal force or funding authority. Organizations that track congressional attention will treat this as an affirmative statement of interest rather than a policy mandate.
Request that governments and nonprofits observe the month
Clause (2) asks federal, state, and local governments and nonprofit organizations to observe the month with programs and activities to increase public knowledge. The clause is phrased as a request rather than a directive; it relies on the voluntary actions of public-health departments and NGOs and may catalyze coordinated awareness campaigns but does not require resource commitments.
Encouragement of lifelong monitoring for survivors
Clause (3) encourages survivors to receive ongoing monitoring and care throughout adulthood. This recommendation highlights survivorship care needs but leaves open who should deliver or pay for that care; clinicians, payers, and regulators would need separate policy or payment shifts to implement systematic long-term monitoring.
Pledge, remembrance, and commendation
Clauses (4) through (6) recognize the human toll, pledge to treat prevention and cure as a public-health priority, remind the public of children's bravery, and commend affected children. These clauses position the House rhetorically in solidarity with patients and families and signal moral support for future policy or funding efforts, but they contain no operational directives or enforcement language.
This bill is one of many.
Codify tracks hundreds of bills on Healthcare across all five countries.
Explore Healthcare in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- Childhood cancer survivors and patients: The resolution raises attention to survivorship needs and could empower survivors and families to push for better long-term follow-up, supportive services, and research.
- Advocacy groups and nonprofits focused on pediatric cancer: Congressional recognition provides a platform for fundraising, public campaigns, and coalition-building during September 2025.
- Pediatric oncology clinicians and centers: Increased public awareness can drive referrals, participation in survivorship programs, and community engagement with clinical research.
- State and local public-health agencies: The resolution legitimizes awareness activities and can help justify local campaigns and partnerships with nonprofits during the designated month.
- Research funders and academics: The public-health framing may strengthen the case for research proposals and targeted funding on late effects and survivorship if followed by legislative or agency action.
Who Bears the Cost
- Nonprofit organizations and advocacy groups: Observance activities, events, and outreach typically require staff time and program budgets, increasing near-term costs even though the resolution does not provide funding.
- State and local public-health departments: If agencies choose to mount campaigns or educational programs in response, they will incur programmatic expenses and staff time without new appropriations.
- Healthcare providers and survivorship clinics: A push for lifelong monitoring could increase demand for follow-up services, creating scheduling and capacity pressures without immediately addressing reimbursement or workforce gaps.
- Federal agencies (symbolic administrative burden): Agencies asked to observe the month may reallocate communications resources or coordinate interagency messaging, which imposes small administrative costs absent dedicated resources.
- Policymakers and legislative staff: The resolution may generate constituent inquiries and pressure for follow-up legislation or funding, increasing workload for offices engaged on pediatric cancer issues.
Key Issues
The Core Tension
The central dilemma is symbolic attention versus substantive action: the resolution elevates childhood cancer on the congressional agenda and can mobilize awareness and advocacy, but by design it avoids committing funding, regulatory change, or concrete mechanisms for the survivorship care it encourages—leaving supporters to decide whether symbolic recognition is sufficient or should be followed by legislation and budgetary commitments.
H. Res. 942 is rhetorically strong but legally thin.
It packages statistics and aspirational directives into a nonbinding resolution that neither creates obligations nor provides resources. That limits immediate impact: awareness activities depend on voluntary actions and existing programs.
The resolutions encouragement of lifelong monitoring highlights a real policy gap—survivorship care coordination and coverage—but the text does not address who pays, which standards to use, or how to measure follow-up uptake.
Implementation questions remain open. If advocates use the resolution as a springboard, the next issues will be financing, clinical standards for survivorship monitoring, and measures of program effectiveness.
There is also a risk of awareness fatigue and fragmentation: multiple overlapping observances and campaigns can dilute messaging unless stakeholders coordinate. Finally, citation of specific statistics anchors the resolution to particular data points; if those data are updated or contested, policymakers and advocates will need to reconcile differences when using the resolution as a communication tool.
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.